Safety and Feasibility of Immuno-OCT
Conditions:   Colon Carcinoma;   Barrett Esophagus;   Gastrointestinal Dysplasia Intervention:   Drug: Bevacizumab-800CW Sponsor:   University Medical Center Groningen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials

Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab
Conditions:   Colorectal Cancer;   Peritoneal Metastases Interventions:   Drug: Irinotecan;   Drug: FOLFOX regimen;   Drug: Bevacizumab Sponsor:   Catharina Ziekenhuis Eindhoven Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition:   Cervical Cancer Interventions:   Drug: TQB2868 injection;   Drug: Paclitaxel injection;   Drug: Cisplatin injection;   Drug: Carboplatin injection;   Drug: Bevacizumab injection Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer
Condition:   Colorectal Cancer Interventions:   Drug: all trans Retinoic Acid;   Drug: Atezolizumab;   Drug: Bevacizumab Sponsors:   University of Texas Southwestern Medical Center;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition:   Cervical Cancer Interventions:   Drug: TQB2868 injection;   Drug: Paclitaxel injection;   Drug: Cisplatin injection;   Drug: Carboplatin injection;   Drug: Bevacizumab injection Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer
Condition:   Colorectal Cancer Interventions:   Drug: all trans Retinoic Acid;   Drug: Atezolizumab;   Drug: Bevacizumab Sponsors:   University of Texas Southwestern Medical Center;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition:   Cervical Cancer Interventions:   Drug: TQB2868 injection;   Drug: Paclitaxel injection;   Drug: Cisplatin injection;   Drug: Carboplatin injection;   Drug: Bevacizumab injection Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials